---
title: "National Health Developments Span Lawsuits, Outbreaks, and Policy Shifts, with Local Implications for Memphis"
url: https://www.herememphis.com/2026/08/06/national-health-developments-span-lawsuits/
date: 2026-08-06T09:45:14+00:00
modified: 2026-08-06T09:45:14+00:00
author: "Marcelino Esquivel"
categories: ["National"]
site: "HEREMemphis"
attribution: "HEREMemphis"
---

# National Health Developments Span Lawsuits, Outbreaks, and Policy Shifts, with Local Implications for Memphis

*Source: [HEREMemphis](https://www.herememphis.com/2026/08/06/national-health-developments-span-lawsuits/) — August 6, 2026 by Marcelino Esquivel*

A federal judge recently dismissed a significant lawsuit against Abbott Laboratories, which had alleged that the company misled shareholders regarding a 2022 recall of its infant formula. The legal action stemmed from the widespread formula shortage that followed the closure of Abbott’s Sturgis, Michigan, plant due to bacterial contamination concerns. The dismissal marks a notable development in the aftermath of a public health crisis that drew national attention and prompted federal intervention to address supply chain disruptions. While the immediate focus of this particular lawsuit was on shareholder disclosures rather than direct consumer injury, its resolution underscores the ongoing legal and financial repercussions for companies involved in large-scale product recalls, particularly in critical sectors like infant nutrition. The broader implications for corporate accountability and investor confidence in the pharmaceutical and food industries remain a subject of close observation, as companies navigate complex regulatory environments and public scrutiny.

Simultaneously, the United States has recorded a 35-year peak in measles cases, a concerning trend attributed by public health officials to declining vaccination rates. Measles, a highly contagious viral disease, was declared eliminated in the U.S. in 2000, a testament to widespread vaccination efforts. However, clusters of cases have re-emerged in recent years, often linked to international travel and localized pockets of unvaccinated individuals. The current surge highlights persistent challenges in maintaining robust community immunity and the critical role of childhood immunizations in preventing the resurgence of preventable diseases. Public health agencies nationwide are grappling with strategies to address vaccine hesitancy and ensure adequate coverage to protect vulnerable populations, including infants and immunocompromised individuals, from the severe complications associated with measles, which can include pneumonia, encephalitis, and even death.

Globally, the Ebola outbreak in the Democratic Republic of Congo continues its expansion, with nearly 3,000 confirmed cases reported. This ongoing public health emergency in Central Africa represents one of the most protracted and complex Ebola outbreaks in history, exacerbated by regional instability, conflict, and challenges in accessing affected communities. Efforts by international health organizations and local authorities to contain the virus are ongoing, involving vaccination campaigns, contact tracing, and safe burial practices. The persistent spread of Ebola, despite the availability of effective vaccines and treatments, underscores the difficulties of disease control in fragile humanitarian settings. The international community remains vigilant, monitoring the outbreak’s trajectory and its potential for broader regional impact, recognizing that global health security is intrinsically linked to local containment efforts.

In a significant regulatory update, the Food and Drug Administration (FDA) is revising its pharmacy compounding policies, specifically concerning certain peptides. The agency has announced its decision to exclude the peptide emideltide from its compounding lists, while simultaneously recommending the inclusion of the peptide Semax. Pharmacy compounding involves the preparation of customized medications for individual patients based on a prescription from a licensed practitioner, often when commercially available drugs do not meet specific patient needs. The FDA’s updated guidance reflects its ongoing efforts to ensure the safety and efficacy of compounded drugs, particularly as new substances emerge and scientific understanding evolves. These policy adjustments are crucial for pharmacists and healthcare providers who rely on clear regulatory frameworks to ensure patient access to tailored medications while upholding safety standards.

Merck has also made substantial strides in global health, signing agreements that cover an experimental HIV pill in 129 countries. These agreements aim to broaden access to a potentially groundbreaking treatment for human immunodeficiency virus, particularly in low- and middle-income countries where the burden of HIV remains significant. The development and distribution of new antiretroviral therapies are vital in the ongoing fight against HIV/AIDS, offering hope for improved patient outcomes and further progress toward disease control. Such international collaborations and licensing agreements are instrumental in accelerating the availability of innovative medicines to populations that historically have faced barriers to access, reflecting a concerted effort by pharmaceutical companies and global health partners to address health inequities.

Meanwhile, Nestle is advocating for simplified food labeling, proposing measures designed to make ingredient recognition easier for consumers. The initiative seeks to streamline the information presented on food packaging, allowing individuals to more readily understand what they are consuming and make informed dietary choices. Consumer advocacy groups and public health experts have long called for clearer labeling standards to combat issues such as hidden sugars, allergens, and complex nutritional information. Nestle’s push for simplification aligns with a broader industry trend toward greater transparency and consumer-friendly communication regarding food products. The outcome of these discussions could influence future regulatory approaches to food labeling, potentially affecting how products are marketed and perceived by shoppers in grocery aisles across the nation.

Further judicial decisions have recently been rendered concerning abortion drugs, reflecting the continuing legal and political complexities surrounding reproductive healthcare access in the United States. These rulings, while specific in their legal scope, contribute to the evolving landscape of abortion access following the overturning of Roe v. Wade. The legal challenges often focus on the regulatory approval and distribution of medications used in medication abortion, with implications for healthcare providers and patients nationwide. The ongoing judicial scrutiny underscores the deeply divided opinions and the persistent legal battles that define this aspect of public health and individual rights.

Finally, the FDA has initiated an investigation into recent cyclosporiasis outbreaks, which have been linked to contaminated lettuce. Cyclosporiasis is an intestinal illness caused by the microscopic parasite *Cyclospora cayetanensis*, typically spread through contaminated food or water. These outbreaks highlight the ongoing challenges in food safety and the complexities of tracing contaminants within the agricultural supply chain. Public health officials are working to identify the specific source of contamination and implement measures to prevent future occurrences. Such investigations are critical for safeguarding public health, ensuring the integrity of the food supply, and informing consumers about potential risks associated with fresh produce.

### Why it matters in Memphis

The array of national and global health developments carries direct implications for the Memphis community. The resurgence of measles cases, driven by declining vaccination rates, poses a tangible public health risk to Shelby County, particularly within institutions like Memphis-Shelby County Schools, where high vaccination coverage is crucial to prevent outbreaks among students and staff. Similarly, the FDA’s evolving policies on pharmacy compounding and the global push for accessible HIV treatments directly affect healthcare providers such as Methodist Le Bonheur Healthcare and Baptist Memorial Health Care, as well as the University of Tennessee Health Science Center, influencing patient care and pharmaceutical access. Furthermore, national food safety investigations, like those concerning cyclosporiasis linked to lettuce, underscore the importance of robust local public health surveillance and safe food handling practices across Memphis’s grocery stores and restaurants, directly impacting the well-being of residents throughout the city.